Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.

Characterization, receptor mapping and blood-brain barrier transcytosis of antibodies to the human transferrin receptor.

Friden PM, Olson TS, Obar R, Walus LR, Putney SD.

J Pharmacol Exp Ther. 1996 Sep;278(3):1491-8.

PMID:
8819537
2.

Enhanced uptake of rsCD4 across the rodent and primate blood-brain barrier after conjugation to anti-transferrin receptor antibodies.

Walus LR, Pardridge WM, Starzyk RM, Friden PM.

J Pharmacol Exp Ther. 1996 May;277(2):1067-75.

PMID:
8627518
3.
4.

NGF and anti-transferrin receptor antibody conjugate: short and long-term effects on survival of cholinergic neurons in intraocular septal transplants.

Granholm AC, Bäckman C, Bloom F, Ebendal T, Gerhardt GA, Hoffer B, Mackerlova L, Olson L, Söderström S, Walus LR, et al.

J Pharmacol Exp Ther. 1994 Jan;268(1):448-59.

PMID:
8301587
5.
6.

Blood-brain barrier penetration and in vivo activity of an NGF conjugate.

Friden PM, Walus LR, Watson P, Doctrow SR, Kozarich JW, Bäckman C, Bergman H, Hoffer B, Bloom F, Granholm AC.

Science. 1993 Jan 15;259(5093):373-7.

PMID:
8420006
7.

Transport of proteins across the blood-brain barrier via the transferrin receptor.

Friden PM, Walus LR.

Adv Exp Med Biol. 1993;331:129-36. No abstract available.

PMID:
8333326
8.

Anti-transferrin receptor antibody and antibody-drug conjugates cross the blood-brain barrier.

Friden PM, Walus LR, Musso GF, Taylor MA, Malfroy B, Starzyk RM.

Proc Natl Acad Sci U S A. 1991 Jun 1;88(11):4771-5.

Supplemental Content

Loading ...
Support Center